Navigation Links
Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
Date:2/28/2008

platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our entrance into the follow-on biologics market may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

<
'/>"/>
SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Dennis R. HIll M.D. Radiation Oncologist at the ... recently there has been a promotion of the idea that ... seed, or low dose rate, brachytherapy for prostate cancer. The ... a shorter half life, and gives a higher biologically effective ... has a higher average energy than the other commonly used ...
(Date:5/24/2013)... Dr. Ingrid Warmuth and Anamaria Newport, MHS, ... proud to announce an Open House at their Swedesboro location, ... June 8th from 10 AM to 2 PM. , ... and staff will be on hand to talk to people ... and provide complimentary cosmetic consultations. There will also be specials ...
(Date:5/24/2013)... Bellingham, WA (PRWEB) May 24, 2013 ... researchers, engineers, and industry suppliers will present technologies ... life at the annual SPIE Optics and ... August. Organized by SPIE, the international society ... the largest international, multidisciplinary optical sciences and technology ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Bed bug cases ... protect themselves from the looming higher risk of becoming the ... a new bed bug guideline. In the guide, the company ... and avoiding them while traveling. , According to ... an increase of bed bug infestation during summer: the warm ...
Breaking Biology Technology:Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3
... US Oncology, Inc . today announced that ... service, has exceeded the $15 million mark and has assisted more ... the launch of Care Advantage in August 2006. , , ... a positive resource to help so many cancer patients obtain lifesaving ...
... PLYMOUTH, Mass., July 9 Harvest Technologies Corp. ( ... sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical ... to treat patients with non-reconstructable Critical Limb Ischemia (CLI) ... is a Harvard Medical international-associated institution based in Chennai, ...
... 9 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), ... the appointment of Gary A. Lyons, to the Company,s board ... on the Poniard board to ten. , , "We ... us as we move toward our goal of commercializing picoplatin ...
Cached Biology Technology:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 2OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 3OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 4Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 3
(Date:5/24/2013)... complex systems like ecosystems can get messy, especially when ... unknowns like climate change. , In a new ... Proceedings of the National Academy of Sciences , researchers ... fundamental assumption at the very heart of a popular ... model how climate changes may impact biodiversity, researchers like ...
(Date:5/24/2013)... A frequently expressed concern in the ongoing public health ... especially those that are nutrient dense. A new ... Provide Most Nutrients Per Penny," published in the journal ... of the best nutritional values in the produce aisle, ... than most other raw vegetables and delivering one of ...
(Date:5/24/2013)... fastest growing open-access publishers, today announces the launch of ... A broad scope journal covering all specialties, Frontiers ... web platform for the research community to publish high ... and interactive peer-review enables fast, fair and constructive review ... of three months from submission to final decision for ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... 2008A study comparing breastfed and formula fed infants across ... are greater than the potential risks associated with infant ... present in breastmilk, according to a report published in ... Breastfeeding Medicine , a peer-reviewed journal published by Mary ...
... ability to view the activity of any chosen gene ... With GeneVision, military commanders could compare gene expression in ... to craving as shoppers moved about a store. "The ... his love-struck dates. Frightening? Perhaps. Ethically suspect? Certainly. ...
... researchers have developed the first natural, nontoxic method ... help diminish the environmental and health concerns that ... materials commonly used in products, from electronics to ... that carbon nanotubes deteriorate when exposed to the ...
Cached Biology News:Benefits of breastfeeding outweigh risk of infant exposure to environmental chemicals in breastmilk 2Real-time gene monitoring developed 2Pitt researchers create non-toxic clean-up method for potentially toxic nano materials 2
Donor feline serum and plasma...
Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....
Complete cell culture media with cytokines...
... available in single head (T2-04 SH) or twin ... portable air and gas applications. Delivering flow up ... environments where DC operation, high performance, low cost, ... Offers ultra-compact size, long life, and high efficiency. ...
Biology Products: